The problem you are solving

PrintedSUN Inc. is addressing the widespread and critical issue of neonatal jaundice, a condition that affects approximately 60% of newborns globally. Neonatal jaundice, if left untreated, can lead to severe health complications such as neurological damage, cerebral palsy, and even death. This condition is particularly prevalent among preterm infants, with 80% of them showing symptoms. The traditional treatment methods for neonatal jaundice, such as phototherapy using fiber optic or LED systems, are often expensive, cumbersome, and inaccessible, especially in low-to-middle-income countries. These methods also contribute significantly to medical waste and environmental concerns due to the toxic metals used in devices like LEDs. Hospital treatments present additional challenges, including restricted parent-infant access and significant parental anxiety. To solve this problem, PrintedSUN Inc. is developing an innovative, portable, and environmentally sustainable treatment using organic light-emitting diode (OLED) technology. This approach offers more than 80% cost savings compared to traditional treatments and aims to reduce hospital readmissions and associated healthcare costs, particularly in resource-limited settings. The OLED technology used by PrintedSUN Inc. is not only cost-effective but also reduces the ecological footprint and medical waste, making healthcare more sustainable and accessible. This problem is critical to address as it impacts both the immediate health of newborns and the long-term well-being of families, particularly in underserved regions. By offering a more accessible and sustainable solution, PrintedSUN Inc. aims to improve global health outcomes and contribute to a greener healthcare system.

Study Title (long)

Intended Use & Areas of Interest

• Skin & Allergy
• Early Childhood & Adolescent

Brief description of how to use

Our Blue Light Phototherapy Wrap (BLiP wrap) is designed to be a leading solution for both hospital and home treatment of neonatal jaundice. Leveraging advanced OLED technology, the wrap provides precise, targeted light within the optimal 460-490 nm range for effective bilirubin breakdown, while enabling continuous phototherapy. This ensures efficient treatment while supporting mother-child bonding, crucial for breastfeeding and faster recovery. We are now focused on customer and market validation and are seeking insights from various stakeholders: • For parents: We would like to learn about your experience managing neonatal jaundice in your child (psychological, financial, and social aspects). Would you consider home phototherapy, and if so, how much would you be willing to pay for such a service? • For physicians: We seek your insights on using bilirubin blankets. How comfortable are you prescribing them, and are they part of your jaundice treatment protocols? Would you consider adopting home phototherapy, and what factors would make it viable? • For wearable health tech companies: What are the key challenges in integrating sensors and optical devices for phototherapy? • For health administrators, policy and decision makers: Key considerations include whether existing frameworks for wearable devices apply. Reimbursement policies are also essential, as they determine if at-home treatments for neonatal jaundice, like the BLiP wrap, qualify for insurance or government reimbursement. Hospital adoption will depend on factors like cost, clinical effectiveness, and hospital decision-makers’ openness to new technologies. Policy decisions could drive or hinder integration. For home care, identifying programs or policies that subsidize at-home phototherapy devices is vital. We are scheduling brief 15-20 minute virtual calls and would greatly appreciate your feedback and time.

Seeking

• Evaluators
• Investors

Target Market

Canada and Outside Canada, ,

Exclusion Criteria

N/A

Evaluation Period

07/10/2024 - 30/06/2025

Evaluator Sex & Age

Male Female Non-binary , From 18 to 99

Evaluator Compensation

TBD

Commitment of Evaluators

A single 15-30 minute interview with the possibility of a follow-up.

Length of Follow-up (Months)

1

Story Inspiration

After undergoing knee surgery to repair my meniscus, I found myself in a routine of physiotherapy that included red light phototherapy. While the treatment was effective, it came with significant drawbacks. I had to attend three sessions, each lasting 30 minutes, which was not only expensive but also took time away from my work. The process was cumbersome, requiring specialized handling by nurses, adding another layer of complexity to an already challenging recovery period. This experience sparked the idea that wearable phototherapy devices could offer a more convenient and accessible solution. By enabling patients to receive treatment in the comfort of their own homes, these devices could reduce the burden on hospitals, minimize the need for frequent appointments, and ultimately lower healthcare costs. This innovation has the potential to revolutionize post-surgical care, making it more patient-centered and efficient.